• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

米诺环素治疗感染后嗅觉障碍:一项双盲、安慰剂对照研究。

Treatment of postinfectious olfactory disorders with minocycline: a double-blind, placebo-controlled study.

机构信息

Smell and Taste Clinic, Department of Otorhinolaryngology, Northwestern University, Chicago, Illinois, USA.

出版信息

Laryngoscope. 2011 Mar;121(3):679-82. doi: 10.1002/lary.21401. Epub 2011 Feb 1.

DOI:10.1002/lary.21401
PMID:21287560
Abstract

OBJECTIVES/HYPOTHESIS: Infection of the upper respiratory tract is one of the most common causes of olfactory loss. One of the possible underlying pathologic pathways is an increase of apoptosis of olfactory receptor neurons. Therefore, treatment with the antibiotic minocycline, which has been shown to act as an antiapoptotic agent, is thought to accelerate improvement of olfactory function. To investigate this idea, 55 patients with postinfectious olfactory dysfunction were tested for their olfactory ability.

STUDY DESIGN

Randomized, prospective, double-blind, placebo-controlled.

METHODS

Olfactory function was examined by means of a standardized psychophysical method (Sniffin' Sticks) before and 7 months after a 3-week treatment with either minocycline (2 × 50 mg/d) or a placebo.

RESULTS

Statistical analyses did not reveal any influence of the treatment on the progress of olfactory function, possibly indicating that pathologic changes other than apoptosis contribute to postinfectious olfactory loss, either on a peripheral level (e.g., scarring/reorganization of the olfactory epithelium) or on a central nervous level.

CONCLUSIONS

In conclusion, the present results indicate that minocycline in the given dosage has little or no effect on the recovery of human olfactory function following postinfectious olfactory loss. However, spontaneous recovery is found in approximately 20% of the patients over an observation period of 7 months.

摘要

目的/假设:上呼吸道感染是嗅觉丧失的最常见原因之一。潜在的病理途径之一是嗅觉受体神经元凋亡增加。因此,使用已被证明具有抗凋亡作用的抗生素米诺环素进行治疗被认为可以加速嗅觉功能的恢复。为了验证这一观点,对 55 例感染后嗅觉功能障碍患者的嗅觉能力进行了测试。

研究设计

随机、前瞻性、双盲、安慰剂对照。

方法

使用标准化的心理物理方法(Sniffin' Sticks)在 3 周的米诺环素(2×50mg/d)或安慰剂治疗前后对嗅觉功能进行检查。

结果

统计分析未发现治疗对嗅觉功能进展有任何影响,这可能表明除了凋亡之外,其他病理变化(如嗅觉上皮的瘢痕/重组)也可能导致感染后嗅觉丧失,无论是在周围水平还是在中枢神经系统水平。

结论

总之,目前的结果表明,在给定剂量下,米诺环素对感染后嗅觉丧失后人类嗅觉功能的恢复几乎没有影响。然而,在 7 个月的观察期内,约有 20%的患者出现自发恢复。

相似文献

1
Treatment of postinfectious olfactory disorders with minocycline: a double-blind, placebo-controlled study.米诺环素治疗感染后嗅觉障碍:一项双盲、安慰剂对照研究。
Laryngoscope. 2011 Mar;121(3):679-82. doi: 10.1002/lary.21401. Epub 2011 Feb 1.
2
Lipoic acid in the treatment of smell dysfunction following viral infection of the upper respiratory tract.硫辛酸治疗上呼吸道病毒感染后嗅觉功能障碍
Laryngoscope. 2002 Nov;112(11):2076-80. doi: 10.1097/00005537-200211000-00031.
3
Treatment of olfactory dysfunction, II: studies with minocycline.嗅觉功能障碍的治疗,II:米诺环素研究
Laryngoscope. 2004 Dec;114(12):2200-4. doi: 10.1097/01.mlg.0000149458.21501.6f.
4
Olfactory function in patients with postinfectious and posttraumatic smell disorders before and after treatment with vitamin A: a double-blind, placebo-controlled, randomized clinical trial.维生素 A 治疗感染后和创伤后嗅觉障碍患者的嗅觉功能:一项双盲、安慰剂对照、随机临床试验。
Laryngoscope. 2012 Sep;122(9):1906-9. doi: 10.1002/lary.23405. Epub 2012 Jul 2.
5
Chronic sinusitis and olfactory dysfunction.慢性鼻窦炎与嗅觉功能障碍。
Otolaryngol Clin North Am. 2004 Dec;37(6):1143-57, v-vi. doi: 10.1016/j.otc.2004.06.003.
6
A local steroid injection method for olfactory loss due to upper respiratory infection.一种用于治疗上呼吸道感染所致嗅觉丧失的局部类固醇注射方法。
Chem Senses. 2005 Jan;30 Suppl 1:i212-3. doi: 10.1093/chemse/bjh189.
7
Local and systemic administration of corticosteroids in the treatment of olfactory loss.局部和全身应用皮质类固醇治疗嗅觉丧失
Am J Rhinol. 2004 Jan-Feb;18(1):29-33.
8
Discordance between olfactory psychophysical measurements and olfactory event related potentials in five patients with olfactory dysfunction following upper respiratory infection.五例上呼吸道感染后嗅觉功能障碍患者嗅觉心理物理学测量与嗅觉事件相关电位之间的不一致性
Chin Med J (Engl). 2009 Jul 5;122(13):1554-7.
9
The effect of intranasal sodium citrate on olfaction in post-infectious loss: results from a prospective, placebo-controlled trial in 49 patients.鼻内注射柠檬酸钠对感染后嗅觉丧失患者嗅觉的影响:49例患者的前瞻性、安慰剂对照试验结果
Clin Otolaryngol. 2017 Jun;42(3):557-563. doi: 10.1111/coa.12789. Epub 2016 Dec 7.
10
[Effects of systemic or topical administration of corticosteroids and vitamin B in patients with olfactory loss].[全身性或局部应用皮质类固醇和维生素B对嗅觉丧失患者的影响]
Laryngorhinootologie. 2004 Nov;83(11):729-34. doi: 10.1055/s-2004-825676.

引用本文的文献

1
The efficacy of olfactory training in improving olfactory function: a meta-analysis.嗅觉训练改善嗅觉功能的疗效:一项荟萃分析。
Eur Arch Otorhinolaryngol. 2024 Oct;281(10):5267-5284. doi: 10.1007/s00405-024-08733-7. Epub 2024 May 27.
2
Interventions for the prevention of persistent post-COVID-19 olfactory dysfunction.预防持续性 COVID-19 后嗅觉功能障碍的干预措施。
Cochrane Database Syst Rev. 2022 Sep 5;9(9):CD013877. doi: 10.1002/14651858.CD013877.pub3.
3
Interventions for the treatment of persistent post-COVID-19 olfactory dysfunction.
治疗持续性 COVID-19 后嗅觉功能障碍的干预措施。
Cochrane Database Syst Rev. 2022 Sep 5;9(9):CD013876. doi: 10.1002/14651858.CD013876.pub3.
4
Could melatonin have a potential adjuvant role in the treatment of the lasting anosmia associated with COVID-19? A review.褪黑素在治疗 COVID-19 相关持续性嗅觉丧失方面可能具有辅助作用吗?综述。
Int J Dev Neurosci. 2022 Oct;82(6):465-470. doi: 10.1002/jdn.10208. Epub 2022 Jul 23.
5
Olfactory dysfunction and COVID-19.嗅觉功能障碍与新型冠状病毒肺炎
Oper Tech Otolayngol Head Neck Surg. 2022 Jun;33(2):141-146. doi: 10.1016/j.otot.2022.04.010. Epub 2022 Apr 29.
6
International consensus statement on allergy and rhinology: Olfaction.国际过敏与鼻科学学会共识声明:嗅觉。
Int Forum Allergy Rhinol. 2022 Apr;12(4):327-680. doi: 10.1002/alr.22929.
7
Treatment strategies for postviral olfactory dysfunction: A systematic review.病毒性嗅觉功能障碍的治疗策略:系统评价。
Allergy Asthma Proc. 2022 Mar 1;43(2):96-105. doi: 10.2500/aap.2022.43.210107.
8
Smell Changes and Efficacy of Nasal Theophylline (SCENT) irrigation: A randomized controlled trial for treatment of post-viral olfactory dysfunction.嗅味改变和鼻腔茶碱(SCENT)冲洗治疗:一项治疗病毒性嗅觉功能障碍的随机对照试验。
Am J Otolaryngol. 2022 Mar-Apr;43(2):103299. doi: 10.1016/j.amjoto.2021.103299. Epub 2021 Dec 3.
9
Interventions for the treatment of persistent post-COVID-19 olfactory dysfunction.针对新冠后持续性嗅觉功能障碍的治疗干预措施。
Cochrane Database Syst Rev. 2021 Jul 22;7(7):CD013876. doi: 10.1002/14651858.CD013876.pub2.
10
Interventions for the prevention of persistent post-COVID-19 olfactory dysfunction.预防 COVID-19 后持续性嗅觉功能障碍的干预措施。
Cochrane Database Syst Rev. 2021 Jul 22;7(7):CD013877. doi: 10.1002/14651858.CD013877.pub2.